Cell Source, Inc. (CLCS)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.52
- As of
Kresmion compiles this page from CLCS's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Cell Source, Inc. (CLCS): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-05-14.
See the full CLCS dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CLCS on one page. Preview it with sample data, then open it live with a free account.
Preview the CLCS dossierActive events for CLCS
No recent events on CLCS in the last 180 days.
FREE, NO ACCOUNT
Every event on CLCS, as it fires
New filings, 13F moves and cross asset events on CLCS land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter.
Recent SEC filings, CLCS
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
CLCS's 10-Q filed May 14, 2026 states:
These conditions raise substantial doubt about our ability to continue as a going concern for at least one year from the date these financial statements are issued.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CLCS
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CLCS on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CLCS in the last 180 days.
Upstream: SEC EDGAR filings for CLCS
Kresmion, "Cell Source, Inc. (CLCS) institutional holdings and SEC filings", data as of 2026-05-14, https://kresmion.com/research/CLCS. Upstream data: SEC EDGAR filings for CLCS.
Link to this data (HTML):
<a href="https://kresmion.com/research/CLCS">Cell Source, Inc. (CLCS) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CLCS on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CLCS for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.